Many other mechanisms involved in how PD-L1 is loaded onto EVs are currently under investigation, and targeting these mechanisms in combination with anti-PD-L1/ PD-1 therapy has potential as an effective treatment for PD-L1-related cancers. This evidence concerns the gene CD274 and cancer.